Saba Capital Management, L.P. bought HQL
May 28, 2024 · Form 4 insider transaction
Saba Capital Management, L.P. bought 8,714 shares of Abrdn Life Sciences Investors at $13.38 per share, a transaction worth $116.6K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
8,714
Price
$13.38
Total value
$116.6K
Role—
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateMay 28, 2024
Filing dateMay 31, 2024
Shares owned after3,260,597
OwnershipIndirect
10b5-1 planNo
AmendedNo